Quest Diagnostics Incorporated
DGX
$178.03
-$0.81-0.45%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.41% | 23.14% | 13.40% | 15.63% | 0.44% |
| Total Depreciation and Amortization | 13.60% | 22.22% | 20.69% | 23.85% | 12.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 229.79% | 220.00% | 46.67% | 42.31% | 147.37% |
| Change in Net Operating Assets | 150.00% | 1,016.67% | 51.61% | -81.03% | 71.62% |
| Cash from Operations | 58.15% | 51.11% | 103.90% | -11.95% | 71.98% |
| Capital Expenditure | -35.85% | -17.39% | -12.50% | -70.83% | -0.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 97.78% | 83.96% | -- | -- | -76,550.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -483.33% | 150.00% | -93.94% | 109.52% | -- |
| Cash from Investing | 87.69% | 38.00% | 46.01% | -340.35% | -1,426.17% |
| Total Debt Issued | -99.46% | -- | -- | -100.00% | 232.01% |
| Total Debt Repaid | -900.00% | -33.22% | -- | 99.76% | 99.83% |
| Issuance of Common Stock | -20.83% | -18.75% | 141.67% | 75.00% | 84.62% |
| Repurchase of Common Stock | -15,100.00% | -- | -82.61% | 45.09% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.95% | -7.14% | -6.33% | -5.00% | -5.00% |
| Other Financing Activities | -78.57% | -100.00% | -25.40% | 2,150.00% | -153.85% |
| Cash from Financing | -113.95% | 19.28% | -266.67% | -230.77% | 2,232.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -77.08% | 164.53% | -70.28% | -139.59% | 2,800.00% |